| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |